Delivery Order SPE2DB22D3301-SPE2DB25FX7WG

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The award, valued at $15,962.76, has an ultimate completion date of August 12, 2024. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a ceiling value of $5,504.81 and a period of performance through January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was competed openly....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $10,641.84 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,074,154 units of the pharmaceutical product PHESGO 600-600 MG-20,000. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as a single award contract. The IDC serves as the primary...
This is a $77,717.82 delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for 1,200-600MG-30,000 units of the pharmaceutical product PHESGO, which is used for treating various medical conditions. The contract has an ultimate completion date of October 21, 2022 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,504.81, is for the delivery of 4566677381 PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 2, 2025. The contract was awarded on December 10, 2024 and does not have a set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,641.84 and is a firm fixed-price delivery order with a completion date of November 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 firm fixed price delivery order contract is for the supply of PHESGO 600-600 MG-20,000 unit 10ML, a medical product. The contract has a completion date of January 27, 2025 and was awarded on January 3, 2025. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award is a firm fixed price delivery order worth $8,159.16 for PHESGO 1,200-600MG-30,000 UNIT 15ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PHESGO pharmaceutical products, valued at $8,159.16. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance period through May 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7WG
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 contract is for the delivery of PHESGO 600-600 mg-20,000 unit 10 ml medical products. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 10:24 AM